SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12B - Securities registration termination [Section 12(b)]:
SEC Accession No. 0001193125-22-029143
Filing Date
2022-02-07
Accepted
2022-02-07 09:00:59
Documents
1
Effectiveness Date
2022-02-07

Document Format Files

Seq Description Document Type Size
1 15-12B d253380d1512b.htm 15-12B 9840
  Complete submission text file 0001193125-22-029143.txt   11062
Mailing Address 3 EAST 28TH STREET 10TH FLOOR NEW YORK NY 10016
Business Address 3 EAST 28TH STREET 10TH FLOOR NEW YORK NY 10016 332-206-0935
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12B | Act: 34 | File No.: 001-38318 | Film No.: 22595645
SIC: 2834 Pharmaceutical Preparations